title: Increased cardiovascular risk in South African patients with Addison's disease.
abstract: Patients with Addison's disease (AD) are believed to be at risk for cardiovascular disease (CVD). South Africa, like the rest of the developing world is experiencing an increase in CVD and patients with AD may be at double the risk of their peers. We wished to explore AD patients' CVD risk factors. A cross-sectional nationwide study in South Africa of patients with AD was conducted. A cohort of 147 patients with AD and 147 healthy control subjects were matched by age, gender, ethnicity, and BMI as far as was possible. Lipoproteins and highly-sensitive C-reactive-protein (hs-CRP) were the main outcome measures. AD patients had significantly higher triglycerides; (p=0.001), lower HDLC (p<0.001), higher hs-CRP (p<0.001), and more small dense LDL; (p=0.002) than controls. Nonesterified fatty acids were lower in patients (p<0.001). Approximately 65% [95% confidence interval (CI 55.6-72.4%)] had hypercholesterolaemia, 75% (CI 64.8-81.2%) had low HDLC, and 75% (CI 68.0-84.1%) had a higher LDLC. Thirteen percent of AD patients had diabetes mellitus, but none of the risk factors differed from the nondiabetics. Only HDLC correlated positively with daily hydrocortisone dose (r=0.32; p=0.005). In conclusion dyslipidaemia is common in South African AD patients; CVD risk assessment and intervention are probably warranted in the management of these patients.
authors.affiliation: Division of Endocrinology Department of Medicine University of Cape Town, Cape Town, South Africa.
authors.forename: I L
authors.initials: IL
authors.lastname: Ross
authors.forename: R
authors.initials: R
authors.lastname: Bergthorsdottir
authors.forename: N S
authors.initials: NS
authors.lastname: Levitt
authors.forename: D A
authors.initials: DA
authors.lastname: Schatz
authors.forename: G
authors.initials: G
authors.lastname: Johannsson
authors.forename: A D
authors.initials: AD
authors.lastname: Marais
mesh_terms: D000224:Addison Disease / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology* / Q000208:ethnology; D000328:Adult; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000208:ethnology / Q000209:etiology*; D016022:Case-Control Studies; D003710:Demography; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013019:South Africa / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D008055:Lipids; D006854:Hydrocortisone